Related Experiment Video
Updated: Jan 16, 2026

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection
Published on: February 20, 2020
Necrotizing Fasciitis Caused by Pseudomonas aeruginosa in an Immunocompromised Patient: A Case With Fulminant
Vera Vieira1, Leonor Simões2, Ana Nogueira2
1Intensive Care Unit, Unidade Local de Saúde da Região de Leiria, Leiria, PRT.
Abstract:
Necrotizing fasciitis is a rare, life-threatening infection involving the subcutaneous tissue and fascia, with potential for rapid progression and high mortality. Here, we report the case of a 56-year-old woman with a history of chronic lymphocytic leukemia (under watchful waiting), hypogammaglobulinemia, and megaloblastic anemia who was admitted to the emergency department with progressive swelling of her right forearm following an insect bite. The patient rapidly developed septic shock with multiorgan failure. Broad-spectrum antibiotics were started, and she underwent urgent surgical debridement. Despite intensive care measures, the patient died within hours of admission. Cultures from the wound and blood grew Pseudomonas aeruginosa. This case illustrates the extreme virulence of Pseudomonas aeruginosa in necrotizing soft tissue infections, particularly in immunocompromised hosts. Early recognition and aggressive multidisciplinary intervention remain key to improving outcomes in this life-threatening condition.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Pyelonephritis I: Introduction
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management

